Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > $1.28

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Nov 22, 2021 12:06pm

120 Views

Post# 34153278

RE:$1.28

Intentionally orchestrated to create perception that 4050 is worthless and Thomvest walks away with IP privately. No institution will put a nickel into it as they have burned a bunch of those houses already.